These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 11250155)

  • 21. Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression.
    Carrano AC; Pagano M
    J Cell Biol; 2001 Jun; 153(7):1381-90. PubMed ID: 11425869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase.
    Koepp DM; Schaefer LK; Ye X; Keyomarsi K; Chu C; Harper JW; Elledge SJ
    Science; 2001 Oct; 294(5540):173-7. PubMed ID: 11533444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2.
    Ungermannova D; Gao Y; Liu X
    J Biol Chem; 2005 Aug; 280(34):30301-9. PubMed ID: 15980415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells.
    Lu L; Schulz H; Wolf DA
    BMC Cell Biol; 2002 Aug; 3():22. PubMed ID: 12188931
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells.
    Lin R; Wang TT; Miller WH; White JH
    Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway.
    Hara T; Kamura T; Nakayama K; Oshikawa K; Hatakeyama S; Nakayama K
    J Biol Chem; 2001 Dec; 276(52):48937-43. PubMed ID: 11682478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accumulation of a form of p27(Kip1) not associated with Cdk-cyclin complexes in transforming growth factor-beta-arrested Mv1Lu cells.
    Taipale M; Tiihonen E; Heiskanen A; Laiho M
    Exp Cell Res; 2000 Aug; 259(1):107-16. PubMed ID: 10942583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: a role for p27 in erythroid differentiation coupled G1 arrest.
    Tamir A; Petrocelli T; Stetler K; Chu W; Howard J; Croix BS; Slingerland J; Ben-David Y
    Cell Growth Differ; 2000 May; 11(5):269-77. PubMed ID: 10845428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
    Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation.
    Appleman LJ; Chernova I; Li L; Boussiotis VA
    Cell Cycle; 2006 Sep; 5(18):2123-9. PubMed ID: 16969077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.
    Spruck C; Strohmaier H; Watson M; Smith AP; Ryan A; Krek TW; Reed SI
    Mol Cell; 2001 Mar; 7(3):639-50. PubMed ID: 11463388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kip1 degradation via the ubiquitin-proteasome pathway.
    Tam SW; Theodoras AM; Pagano M
    Leukemia; 1997 Apr; 11 Suppl 3():363-6. PubMed ID: 9209391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell-free degradation of p27(kip1), a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome.
    Nguyen H; Gitig DM; Koff A
    Mol Cell Biol; 1999 Feb; 19(2):1190-201. PubMed ID: 9891053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell cycle-dependent phosphorylation of p27 cyclin-dependent kinase (Cdk) inhibitor by cyclin E/Cdk2.
    Morisaki H; Fujimoto A; Ando A; Nagata Y; Ikeda K; Nakanishi M
    Biochem Biophys Res Commun; 1997 Nov; 240(2):386-90. PubMed ID: 9388487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protein-protein interactions involved in the recognition of p27 by E3 ubiquitin ligase.
    Xu K; Belunis C; Chu W; Weber D; Podlaski F; Huang KS; Reed SI; Vassilev LT
    Biochem J; 2003 May; 371(Pt 3):957-64. PubMed ID: 12529174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noncatalytic requirement for cyclin A-cdk2 in p27 turnover.
    Zhu XH; Nguyen H; Halicka HD; Traganos F; Koff A
    Mol Cell Biol; 2004 Jul; 24(13):6058-66. PubMed ID: 15199159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.
    Pavlides SC; Huang KT; Reid DA; Wu L; Blank SV; Mittal K; Guo L; Rothenberg E; Rueda B; Cardozo T; Gold LI
    Endocrinology; 2013 Nov; 154(11):4030-45. PubMed ID: 24035998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substrate recognition and ubiquitination of SCFSkp2/Cks1 ubiquitin-protein isopeptide ligase.
    Xu S; Abbasian M; Patel P; Jensen-Pergakes K; Lombardo CR; Cathers BE; Xie W; Mercurio F; Pagano M; Giegel D; Cox S
    J Biol Chem; 2007 May; 282(21):15462-70. PubMed ID: 17409098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.
    Carrano AC; Eytan E; Hershko A; Pagano M
    Nat Cell Biol; 1999 Aug; 1(4):193-9. PubMed ID: 10559916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.